Surgical Treatment for Legg-Calvé-Perthes Disease in Children | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital at NYU Langone may recommend surgery for children with severe symptoms of Legg-Calvé-Perthes disease.
Surgical Treatment for Preterm Labor | NYU Langone Health
NYU Langone doctors use cervical cerclage, a surgical procedure to close the cervix, for some women experiencing early preterm labor.
Surgical Treatment for Staphylococcal Infections | NYU Langone Health
NYU Langone doctors recommend surgery to clean a wound if a staphylococcal, or staph, infection is severe.
Surgical Treatment for Voice Disorders | NYU Langone Health
Experts at NYU Langone’s Voice Center provide surgical care for voice-related conditions.
Surgical Weight Loss | NYU Langone Health
At NYU Langone’s Weight Management Program, we are leaders in bariatric surgery to help patients lose weight and improve their overall health.
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly
Fetal complete (i.e., third degree) atrioventricular block (AVB), identified in the 2nd trimester of pregnancy in an otherwise normally developing heart, is almost universally associated with maternal anti-Ro autoantibodies and results in death in a fifth of cases. To date no treatment of 3° AVB has been effective, which may be because current surveillance is limited to once- weekly fetal echocardiograms. This study comprises three steps: 1) to screen for high titer anti-Ro antibodies, which are necessary but not sufficient to develop fetal AVB; 2) to empower mothers to identify 2° AVB by using fetal heart rate and rhythm monitoring (FHRM) at home, and 3) to rapidly treat mothers who detect an abnormality by monitoring with an urgent echocardiogram that confirms 2° AVB with the hope of reversing 2° AVB before it becomes permanent (3° AVB). In addition, it will be determined if FHRM reduces the need for weekly echoes. Although mothers with low titer anti-Ro will not be continued in Step 2 and therefore not followed by FHRM, birth ECGs will be collected to confirm that high titer antibodies confer risk.
Surveillance for Neurofibromatosis | NYU Langone Health
NYU Langone doctors may use surveillance, or monitoring, to help manage neurofibromatosis.
Survey to assess preference for colon cancer screening test
This survey-based study aims to understand patient preferences and decision making when choosing from colorectal cancer screening test options. Our aim is to understand patient preferences when it comes to blood-based testing, stool-based testing, and colonoscopy in order to help direct research efforts in the future.
Survivorship Program at Perlmutter Cancer Center | NYU Langone Health
The Survivorship Program at NYU Langone’s Perlmutter Cancer Center helps patients live their best lives during and after cancer.
Sustainability | NYU Langone Health
NYU Langone Health is committed to being carbon neutral by 2050, reducing our impact on the environment and conserving resources.